False Certainty of evidence: high provisional C-GUT-06

Redefining peptic ulcer as an H. pylori infection was a 'crime'; the real problem is low stomach acid, and acid blockers plus antibiotic 'triple therapy' are the wrong treatment.

Safety note: Untreated H. pylori-related ulcers can bleed or perforate and the infection increases gastric cancer risk; eradication therapy is the medically accepted treatment.
Conclusion: False: treating H. pylori prevents ulcer recurrence and reduces stomach cancer risk.

Original statement

الراجل ده الجحش ده عمل نقله نوعيه وجريمه حول القرحه من ستريس وهو تعريف غلط اصلا خلاه عدوى | نقص افراز المعده موجود عند كل الناس اللي مش معايا دغري وسكه كده يعني اي حد اسم ضياء العوضي مش جنبه عنده نقص في حمض المعده ده مبدئيا بيشرب شاي بقى بيشرب كازوزه ا بيدي بياخد كونترلاك بياخد نيكسيوم بياكل دقيق بياكل مكرونه بياكل اندومي اي دقيق ابيض ولازق على الجدار الاتش س ال بتاعك اقل من الطبيعي

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Redefining peptic ulcer as an H. pylori infection was a 'crime'; the real problem is low stomach acid, and acid blockers plus antibiotic 'triple therapy' are the wrong treatment.

Origin

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
Dr Diaa Al Awady د ضياء العوضي is live! الجرثومة (Open source)
Published
8 December 2025
Timestamp
not available (transcript has no timings)
Attribution uncertainty
Machine-generated or CC transcript of a live stream; wording may contain transcription errors; context is conversational. original_ar joins separate verbatim passages with ' | '.
Claimed mechanism

Ulcers come from stress/diet and hypochlorhydria; bacteria are not the cause.

Claimed health effect

Unnecessary antibiotic and PPI use.

Population concerned

People with H. pylori or ulcers.

Geographic restriction by Elawady

none found

Diverging source versions

نقص افراز المعده موجود عند كل الناس اللي مش معايا دغري وسكه كده يعني اي حد اسم ضياء العوضي مش جنبه عنده نقص في حمض المعده ده مبدئيا بيشرب شاي بقى بيشرب كازوزه ا بيدي بياخد كونترلاك بياخد نيكسيوم بياكل دقيق بياكل مكرونه بياكل اندومي اي دقيق ابيض ولازق على الجدار الاتش س ال بتاعك اقل من الطبيعي

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
Dr Diaa Al Awady د ضياء العوضي is live! الجرثومة (Open source)
Published
8 December 2025
Timestamp
0:42:08 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)

بيشرب شاي بقى بيشرب كازوزه ا بيدي بياخد كونترالاك بياخد نيكسيوم بياكل دقيق بياكل مكرونه بياكل اندومي اي دقيق ابيض ولازق على الجدار الاتش سي ال بتاعك اقل من الطبيعي خلاص بنسميها الاكلوروهايد

He drinks tea, drinks soda, takes Controloc, takes Nexium, eats flour, eats pasta, eats Indomie - any white flour, stuck on the wall - your HCl is lower than normal; we call it achlorhydria.

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
حقيقه جرثومه المعده . #ضياء_العوضي (Open source)
Published
15 December 2025
Timestamp
0:31:21 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); no timestamps; wording may contain speech-recognition errors; speaker turns are not marked, the excerpt was judged to be Elawady's own speech from context.

Scientific assessment

False – The statement contradicts the robust evidence.

Certainty of evidence: high – Further research is very unlikely to change the assessment.

1. What was claimed?

H. pylori as ulcer cause is a scientific crime; low acid is the real cause.

2. What is demonstrably correct?

Rising antibiotic resistance is a real challenge, and stress, NSAIDs and other factors also contribute to ulcers.

3. What is wrong or exaggerated?

Randomised trials show that curing H. pylori prevents ulcer recurrence and reduces gastric cancer; the bacterium is formally recognised as an infectious disease (ICD-11).

4. What remains unclear?

Optimal regimens vary by local resistance patterns.

5. Which studies support it?

None.

6. Which studies contradict it?

Ford 2016 Cochrane (I-GUT-02), Ford 2020 (I-GUT-03), Maastricht VI (I-GUT-01).

7. What applies to Germany and Europe?

European guidelines follow Maastricht VI.

8. What is known about Egypt?

H. pylori infection is common in many countries; local resistance patterns matter. No Egypt-specific data were reviewed.

9. What practical conclusion is appropriate?

People with H. pylori-related ulcers benefit from eradication therapy; refusing it raises the risk of recurrent ulcers, bleeding and gastric cancer.

Assessment details

Rationale for certainty of evidence

Cochrane review of RCTs: eradication therapy greatly reduces duodenal and gastric ulcer recurrence versus no treatment (RR 0.20 and 0.31); RCT meta-analysis: eradication reduces gastric cancer incidence (RR 0.54) and gastric cancer mortality (RR 0.61) in healthy infected people (mostly East Asian trials). The Maastricht VI consensus treats H. pylori as an infectious disease that should be treated.

Source quality

Video statement contradicting well-established, RCT-confirmed evidence.

Regional transferability

High; trials span many countries.

Individual exceptions

Antibiotic resistance makes regimen choice important.

Regional scope of the claim
general (biological/medical)
Last reviewed
25 October 2026 provisional

In plain language

The discovery that a bacterium, H. pylori, causes most stomach and duodenal ulcers changed medicine. Trials show that treating the infection prevents ulcers from coming back and lowers the risk of stomach cancer. Calling this discovery a crime contradicts strong evidence.

Studies on this claim

Studies supporting the claim (0)

No studies in this group.

Studies contradicting or limiting the claim (3)

  • Treating H. pylori prevents ulcers returning (Cochrane)

    Ford AC et al.. Cochrane Database Syst Rev 2016 · PMID 27092708 · DOI 10.1002/14651858.CD003840.pub5
    Meta-analysisindependent cross-checkabstract only checked★ key study

    Duodenal ulcer recurrence fell from 64% without treatment to 13% with eradication.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Ulcer treatment.

    How was the study done?

    Cochrane review.

    How many people, animals or samples were studied?

    Thousands.

    What was actually found?

    Fewer recurrences.

    How large was the observed effect?

    RR 0.20.

    What do the results mean in everyday life?

    Eradication works.

    What are the study's limitations?

    Older trials.

    What does it say about Elawady's specific claim?

    Contradicts C-GUT-06.

    Do the results apply to Germany and Europe?

    Applicable.

    Scientific details →

  • H. pylori treatment and stomach cancer

    Ford AC et al.. Gut 2020 · PMID 32205420 · DOI 10.1136/gutjnl-2020-320839
    Meta-analysisindependent cross-checkabstract only checked

    Eradication nearly halved gastric cancer incidence in trials.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    GC prevention.

    How was the study done?

    MA of RCTs.

    How many people, animals or samples were studied?

    10,164.

    What was actually found?

    Fewer cancers.

    How large was the observed effect?

    RR 0.54.

    What do the results mean in everyday life?

    Treating infection prevents cancer.

    What are the study's limitations?

    East Asian.

    What does it say about Elawady's specific claim?

    Contradicts C-GUT-06.

    Do the results apply to Germany and Europe?

    Moderate.

    Scientific details →

  • Maastricht VI: H. pylori management

    Malfertheiner P et al.. Gut 2022 · PMID 35944925 · DOI 10.1136/gutjnl-2022-327745
    Guideline / position statementindependent cross-checkabstract only checked

    H. pylori is an infectious disease; infected people should be treated.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    H. pylori guidance.

    How was the study done?

    Consensus.

    What was actually found?

    Treat all infected.

    What do the results mean in everyday life?

    Treatment is standard.

    What are the study's limitations?

    Consensus; COI.

    What does it say about Elawady's specific claim?

    Contradicts C-GUT-06.

    Do the results apply to Germany and Europe?

    European.

    Scientific details →

Studies with mixed or unclear results (0)

No studies in this group.

Regional context

Germany / EU

European guidelines follow Maastricht VI.

Egypt

H. pylori infection is common in many countries; local resistance patterns matter. No Egypt-specific data were reviewed.

What applies in my country?

General scientific assessment

False False: treating H. pylori prevents ulcer recurrence and reduces stomach cancer risk.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

  1. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.. Ford AC et al.. Cochrane Database Syst Rev 2016 · PMID 27092708 · DOI 10.1002/14651858.CD003840.pub5
  2. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis.. Ford AC et al.. Gut 2020 · PMID 32205420 · DOI 10.1136/gutjnl-2020-320839
  3. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report.. Malfertheiner P et al.. Gut 2022 · PMID 35944925 · DOI 10.1136/gutjnl-2022-327745

← Back to overview